Promise of improving metabolic and lifestyle risk in practice

The Lancet

Volumn 371, Issue 9629, 2008, Pages 1973-1974

  Mozaffarian, Dariush ^a,b  

^a CHANNING LABORATORY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET RESTRICTION; FAMILY CENTERED CARE; HEALTH CARE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; INTERVENTION STUDY; LIFESTYLE; LIFESTYLE MODIFICATION; LIPOPROTEIN BLOOD LEVEL; METABOLIC BALANCE; METABOLIC DISORDER; PHYSICAL ACTIVITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; SMOKING CESSATION; TREATMENT OUTCOME; TREATMENT PLANNING; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EUROPE; FAMILY; HEALTH PROMOTION; METHODOLOGY; MULTICENTER STUDY; NOTE; RANDOMIZED CONTROLLED TRIAL;

CARDIOVASCULAR DISEASES; EUROPE; FAMILY; HEALTH PROMOTION; HUMANS; LIFE STYLE; RISK FACTORS;

EID: 44949107201     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60844-2     Document Type: Note

References (10)

1. EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 357 (2001) 995-1001
2. Brunner E., Cohen D., and Toon L. Cost effectiveness of cardiovascular disease prevention strategies: a perspective on EU food based dietary guidelines. Public Health Nutr 4 (2001) 711-715
3. Graham I., Atar D., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 28 (2007) 2375-2414
4. Newby L., LaPointe N., Chen A., et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 113 (2006) 203-212
5. Chowdhury P., Balluz L., Murphy W., et al. Surveillance of certain health behaviors among states and selected local areas-United States, 2005. MMWR Surveill Summ 56 (2007) 1-160
6. Thorndike A., Regan S., and Rigotti N. The treatment of smoking by US physicians during ambulatory visits: 1994-2003. Am J Public Health 97 (2007) 1878-1883
7. Wofford T., Greenlund K., Croft J., and Labarthe D. Diet and physical activity of U.S. adults with heart disease following preventive advice. Prev Med 45 (2007) 295-301
8. Lutfiyya M., Nika B., Ng L., Tragos C., Won R., and Lipsky M. Primary prevention of overweight and obesity: an analysis of national survey data. J Gen Intern Med 23 (2008) 821-823
9. Wood D., Kotseva K., Connolly S., et al., on behalf of EUROACTION Study Group. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 371 (2008) 1999-2012
10. Mozaffarian D, Wilson PWF, Kanel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation (in press).